14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $13.80 $16.06 Friday, 3rd May 2024 CNCR stock ended at $15.86. This is 2.79% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.27% from a day low at $15.70 to a day high of $15.90.
90 days $13.80 $17.96
52 weeks $9.22 $17.96

Historical Loncar Cancer Immunotherapy ETF prices

Date Open High Low Close Volume
May 03, 2024 $15.90 $15.90 $15.70 $15.86 5 947
May 02, 2024 $15.57 $15.61 $15.25 $15.43 10 929
May 01, 2024 $15.00 $15.83 $14.94 $15.44 82 705
Apr 30, 2024 $15.07 $15.10 $14.76 $14.76 15 798
Apr 29, 2024 $14.65 $15.27 $14.65 $15.03 21 494
Apr 26, 2024 $13.97 $14.43 $13.94 $14.39 3 217
Apr 25, 2024 $14.26 $14.26 $13.80 $13.95 6 363
Apr 24, 2024 $14.53 $14.53 $14.23 $14.23 2 093
Apr 23, 2024 $14.44 $14.65 $14.44 $14.48 2 452
Apr 22, 2024 $14.18 $14.48 $14.05 $14.21 6 823
Apr 19, 2024 $14.30 $14.46 $13.92 $14.11 14 954
Apr 18, 2024 $14.58 $14.63 $14.36 $14.36 1 755
Apr 17, 2024 $14.89 $14.89 $14.57 $14.57 225 723
Apr 16, 2024 $14.97 $15.00 $14.67 $14.67 30 060
Apr 15, 2024 $15.59 $15.59 $15.00 $15.01 17 925
Apr 12, 2024 $15.91 $15.91 $15.32 $15.64 4 446
Apr 11, 2024 $15.74 $16.00 $15.67 $15.95 4 863
Apr 10, 2024 $15.53 $15.68 $15.40 $15.55 9 417
Apr 09, 2024 $15.78 $16.00 $15.69 $16.00 19 252
Apr 08, 2024 $15.73 $15.73 $15.44 $15.54 7 130
Apr 05, 2024 $15.48 $15.75 $15.37 $15.70 4 676
Apr 04, 2024 $16.03 $16.06 $15.47 $15.53 5 502
Apr 03, 2024 $15.74 $15.87 $15.54 $15.87 10 798
Apr 02, 2024 $16.17 $16.17 $15.73 $15.73 7 837
Apr 01, 2024 $16.58 $16.58 $16.11 $16.29 13 641
Click to get the best stock tips daily for free!

About Loncar Cancer Immunotherapy ETF

The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The fund attempts to invest all, or substantiall... CNCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT